Dr. Daniel Bowles, MD
Claim this profileUniversity of Colorado Hospital
Studies Cancer
Studies Salivary Gland Tumors
6 reported clinical trials
11 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage II
2Salivary Gland Tumors
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Daniel Bowles, MD is currently running
High Dose Testosterone
for Prostate Cancer
This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermittent high dose testosterone. This therapy may result in responses in tumors which are genetically unstable because of DNA repair deficiency and this is a prospective study to test that hypothesis
Recruiting3 awards Phase 2
Trastuzumab Emtansine
for Salivary Gland Cancer
This phase II trial tests whether ado-trastuzumab emtansine works to shrink tumors in patients with HER2-positive salivary gland cancer that has come back (recurrent), spread to other places in the body (metastatic), or cannot be removed by surgery (unresectable). Trastuzumab emtansine is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug called emtansine. Trastuzumab attaches to HER2 positive cancer cells in a targeted way and delivers emtansine to kill them. Trastuzumab emtansine may work better compared to usual treatment of chemotherapy with docetaxel and trastuzumab in treating patients with salivary gland cancer.
Recruiting1 award Phase 2
More about Daniel Bowles, MD
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Daniel Bowles, MD has experience with
- Atezolizumab
- Stereotactic Body Radiation Therapy
- High Dose Testosterone
- Rivoceranib
- ONC-392
- Pembrolizumab
Breakdown of trials Daniel Bowles, MD has run
Cancer
Salivary Gland Tumors
Salivary Gland Cancer
Prostate Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Bowles, MD specialize in?
Daniel Bowles, MD focuses on Cancer and Salivary Gland Tumors. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Daniel Bowles, MD currently recruiting for clinical trials?
Yes, Daniel Bowles, MD is currently recruiting for 4 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Daniel Bowles, MD has studied deeply?
Yes, Daniel Bowles, MD has studied treatments such as Atezolizumab, Stereotactic Body Radiation Therapy, High dose testosterone.
What is the best way to schedule an appointment with Daniel Bowles, MD?
Apply for one of the trials that Daniel Bowles, MD is conducting.
What is the office address of Daniel Bowles, MD?
The office of Daniel Bowles, MD is located at: University of Colorado Hospital, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.